Search alternatives:
ng decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1941
Preferential S-phase Est2 binding at short telomeres is decreased in <i>pif1-m2</i> cells.
Published 2015“…Each arrowhead represents ~100 bp C<sub>1-3A</sub>/TG<sub>1-3</sub> DNA. The 34 bp FRT recognition sites are labeled. …”
-
1942
Triton X-100 (TX-100) attenuated the recovery of cardiac function during reperfusion in Langendorff-perfused hearts subjected to ischemia and reperfusion (I/R) injury.
Published 2013“…<p>(A) +dP/dt (maximum rate of increase of LVDP); (B) -dP/dt (maximum rate of decrease of LVDP). …”
-
1943
-
1944
-
1945
Effects of hNGFP61S/R100E on Aβ plaque load revealed by immunohistochemistry, Thioflavin S staining and ELISA.
Published 2012“…(<b>C,F</b>) The intranasal administration of 540 ng/kg of hNGFP61S/R100E decreases the plaque load. (<b>G,H</b>) The treatment with hNGFP61S/R100E determined a shift from fibrillar (<b>G</b>) to more compact morphology of the remaining plaques (<b>H</b>). …”
-
1946
-
1947
-
1948
Soluble S100B or Aβ42 treatment promotes mitochondrial H<sub>2</sub>O<sub>2</sub> production, loss in mitochondrial membrane potential and apoptosis in normal cultured HNPs.
Published 2011“…MitoPY1 localizes to the mitochondria and directly assays H<sub>2</sub>O<sub>2</sub> levels in the organelle. S100B treatment also leads to mitochondrial dysfunction in a dose-dependent fashion, as showed by decreased MitoTracker deep red staining (rhodamine). …”
-
1949
Sequence of <i>DpAP2</i> promoter.
Published 2024“…<i>parva</i> cells treated with different concentrations of MeJA (10, 20, 50, 100 μM) and GA3 (10, 20, 50, 100 μM). The high concentrations of MeJA (10–100 μM) inhibited the accumulation of carotenoid, and the relative expression of <i>DpAP2</i>, <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> decreased significantly. …”
-
1950
Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter.
Published 2024“…<i>parva</i> cells treated with different concentrations of MeJA (10, 20, 50, 100 μM) and GA3 (10, 20, 50, 100 μM). The high concentrations of MeJA (10–100 μM) inhibited the accumulation of carotenoid, and the relative expression of <i>DpAP2</i>, <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> decreased significantly. …”
-
1951
-
1952
-
1953
-
1954
-
1955
-
1956
-
1957
-
1958
-
1959
-
1960